5d 1m 3m 1y 5y 10y
There are no Transcripts on HRTX.
Business Wire (Jan 23, 2014)
HRTX vs. ETF Alternatives
Wednesday, Mar 58:19 AM
Thursday, Mar 282013, 2:12 PMAP Pharma (APPA.OB -32.6%) dives after FDA denies approval for chemotherapy nausea treatment citing issues with AP's syringe administration system and manufacturing facilities. SA contributor Smith on Stocks says the issues are resolvable and, consistent with the company's own projections, sees approval in H1 2014. |Thursday, Mar 282013, 2:12 PM| Comment!
Monday, Jan 142013, 2:32 PMInvestors interested in the prospects of young biotech companies might want to take a look at this Seeking Alpha article. It's a list of the upcoming FDA approval decision dates for Q1 2013, and with many of these developing firms having a good portion of their businesses riding on FDA approval decisions for their newly developed drugs, the stocks are likely to be sensitive to any positive or negative news over the near term. |Monday, Jan 142013, 2:32 PM| Comment!